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We found a signiﬁcant correlation between lung cancer in smokers and the expression of a human gene, D40, predominantly
expressed in testis and cancers. In an attempt to clone a novel human gene, we screened a cDNA library derived from a
human B cell line and obtained a cDNA clone that we refer to as D40. A search for public databases for sequence
homologies showed that the D40 gene is identical to AF15q14. D40 mRNA is predominantly expressed in normal testis
tissue. However, this gene is also expressed in various human tumour cell lines and primary tumours derived from various
organs and tissues, such as lung cancer. We examined the relationship between D40 expression and clinico-pathological
characteristics of tumours in primary lung cancer. D40 expression did not signiﬁcantly correlate with either histological type or
pathological tumour stage. However, D40 expression was observed more frequently in poorly differentiated tumours than in
well or moderately differentiated ones. Furthermore, the incidence of D40 expression was signiﬁcantly higher in tumours from
patients who smoke than in those from non-smokers. D40/AF15q14 is the ﬁrst gene in the cancer/testis family for which
expression is related to the smoking habits of cancer patients.
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Tumour cells often express genes that are otherwise expressed in
normal cells at very low levels if at all (Bishop, 1987). Such aber-
rantly expressed genes include proto-oncogenes and those involved
in tissue-speciﬁc differentiation. The expression of these genes in
tumour cells probably contributes to the malignant phenotypes
and the recognition of tumour cells by the host immune system
(Boon et al, 1997).
The testis, an essential organ of the male reproductive system,
produces spermatozoa in which genetic information is stored with-
in the haploid genome (Bloom and Fawcett, 1994). Of the dozens
of genes that are expressed in the testis, some are expressed in a
testis-speciﬁc manner related to spermatogenesis. Whereas most
testis-speciﬁc genes are either never or very rarely activated in
tumours (De Smet et al, 1997), recent studies have identiﬁed a
class of genes that is expressed both in the normal testis and in
cancerous tissue. Some of them elicit an immune response in hosts
and are called cancer/testis (CT) antigen (Boon et al, 1997; Chen
and Old, 1999). Others, for which the antigenicity remains
unknown, are expressed in similar manner to CT. Some of these
display sequences homology to CT and are expressed not only in
testes but also in other male and female reproductive organs
(Brinkmann et al, 1998). Overall, these may all be referred to CT
family genes or CT genes. Their potential application in the diag-
nosis and immunogene therapy of cancer has been extensively
studied (Boon et al, 1997; Chen and Old, 1999). However, little
is known about either clinico-pathological features of their expres-
sion in tumours or their physiological functions. This information
is very important in characterisation of CT genes and when consid-
ering immunotherapy with these genes. Understanding the clinico-
pathological characteristics of their expression would facilitate
determination of which CT gene product should be selected as
tumour targets for therapy.
In this study, we report on a human gene, D40, that is primarily
expressed in normal testis tissues. Initially, we searched for proteins
that interact with the transcription factor GCF using the yeast two-
hybrid system (Kageyama and Pastan, 1989; Chien et al, 1991).
After we obtained a cDNA clone, D40, that binds to GCF, we later
discovered that the reported GCF cDNA clone is chimeric, consist-
ing of two different cDNA fragments. One was derived from the
GCF2 transcription factor and the other was from unrelated gene
product with unknown function (Reed et al, 1998; Takimoto et
al, 1999). D40 protein binds to the latter. A sequence homology
search revealed that D40 is the same gene as AF15q14 which was
recently identiﬁed as one of the genes that fuses with an oncogenic
gene MLL (mixed lineage leukaemia) in acute leukaemia (Hayette
et al, 2000). While the D40 gene is barely expressed in normal
tissues except for the testis, it is expressed frequently in various
human cancer cell lines and primary tumours derived from differ-
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the CT family. Furthermore, the incidence of D40 expression is
signiﬁcantly higher in poorly differentiated primary lung cancer
and in cancers from patients with a smoking habit. To our know-
ledge, D40/AF15q14 is the ﬁrst gene in the CT family for which
expression is signiﬁcantly related to smoking habits of the patients
with cancer.
MATERIALS AND METHODS
Cultured cell lines, tumour samples, and patients
Cell lines used in this study are described in Table 1. The cultured
cells were maintained in RPMI 1640 or DMEM with 10% foetal
calf serum and 0.3 mg ml
71 L-glutamine. Cells were cultured at
378C in a 5% CO2 atmosphere. Primary tumour samples obtained
from surgical operations were quickly frozen in liquid nitrogen and
stored at 7808C until RNA isolation. Experiments on surgical
samples were performed after obtaining written informed consent
from the patients. Sections of tumour specimens were reviewed
by pathologists. Lung tumour specimens were histopathologically
diagnosed according to the 1981 World Health Organization clas-
siﬁcation (WHO, 1982). The postsurgical pTMN stage was
determined according to the guidelines of the American Joint
Committee on Cancer (Bearhs et al, 1992). Smokers analysed in
this study were current smokers, including individuals who stopped
smoking 3 months before surgery. Non-smokers were those who
had never smoked.
cDNA cloning and DNA sequencing of D40
The carboxy terminal two-thirds of the coding region of the
previously described transcription factor GCF (Kageyama and
Pastan, 1989) was subcloned into pGBT-9 (Clontech) and the
resultant plasmid was used in yeast two-hybrid screening with
the yeast strain Y153 and a cDNA library of a human B cell line
(Fields and Song, 1989; Chien et al, 1991; Durfee et al, 1993).
Out of 1.2 million yeast clones screened, nine were positive for
both histidine and LacZ phenotypes. After conﬁrming that one
of the clones possessed binding speciﬁcity, we determined the
nucleotide sequences. We screened a cDNA library from a human
promyelocytic leukaemia HL60 cell line for longer clones using this
clone. Rapid ampliﬁcation of cDNA ends (RACE) (Frohman et al,
1988) was performed with the D40-speciﬁc primers and the proto-
col provided with a commercial 5'/3' RACE kit (Boehringer/
Roche). For DNA sequencing, plasmid DNAs prepared with a
commercial column (Qiagen) served as templates in cycle sequen-
cing reactions performed using dideoxy chain termination (Sanger
et al, 1977) Sequence were analysed using ﬂuorescence DNA
sequencers. Public databases on the Internet were searched for
sequence homology.
RNA isolation
Total RNA from cell lines and tumour samples was isolated and
puriﬁed by the acid-guanidinium-phenol chloroform method
(Chomczynski and Sacchi, 1987). Approximately 1610
7 cells or
80 mg of tumour tissues were homogenised in 2 ml of Trizol
reagent (Life Technology) to purify the RNA.
Northern blot analyses
Northern blot analyses were performed as described (Sambrook et
al, 1989). Probe DNAs were radiolabelled with a-
32P-dCTP using a
commercial random priming kit (Takara, Kyoto, Japan). Hybridi-
sation proceeded in 50% formamide, 56SSC, 56Denhardt’s
solution and 0.5% SDS at 378C overnight. Blotted membranes were
then washed at progressively higher stringency. The membranes
were ﬁnally washed in 0.26SSC containing 0.1% SDS at 488C.
Signals were detected using a BAS2000 (Fuji Film, Tokyo, Japan).
Reverse transcription polymerase chain reaction (RT–
PCR)
Total RNA (1 mg) was reverse-transcribed to cDNA with a reverse
primer, MT152 (5'- TCCCATCTTCTGATGTG-3'), and Superscript
II RNase H
7 reverse transcriptase (Life Technology). Ampliﬁcation
was performed with 0.1 mg cDNA, 10 pmol of D40-speciﬁc oligo-
nucleotides (forward: MT149; 5'-CACATCCAGTGAGACCA-3',
reverse: MT152), and 0.5 units of Taq polymerase in a total reac-
tion volume of 20 ml with a buffer containing 10 mM Tris-HCl,
1.5 mM MgCl2, and 50 mM KCl, pH 8.3. Primers for b-actin were
used in the ampliﬁcation to check the RNA integrity.
Statistical analysis
Associations between D40 expression and categorical variables were
analysed by the w
2 test or Fisher’s extract test as appropriate
(Mehta and Patel, 1983). Associations between D40 expression
and age were analysed by the Student’s t-test. The signiﬁcance level
was P50.05 and all tests were two-sided.
RESULTS
Identiﬁcation and cloning of the human gene D40
In an attempt to clone a novel human gene, we performed two-
hybrid screening of the cDNA library derived from a human B cell
line using the transcription factor GCF (Kageyama and Pastan,
1989) as bait and were able to obtain a cDNA clone that we called
D40. DNA sequencing analyses revealed that the clone had an open
reading frame. Using a part of the clone as a probe, a cDNA library
from a human leukaemia cell line was screened to obtain longer
clones. During the course of cloning, we noticed that the initial
D40 clone had a deletion of a nucleotide in the middle of the
coding region that leads to an occurrence of a stop codon several
bases downstream of the deletion (Takimoto, 1999). As none of the
other clones had in-frame stop codons at both ends, we performed
rapid ampliﬁcation of cDNA ends (RACE). We were able to ﬁnd
the clones that had an in-frame stop codon in the 5' end and those
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Table 1 Human cancer cell lines that express D40 mRNA
Cell type Name of cell line
Lung cancer PI10
NCIH226
RERF-LC-MS
RERF-LC-OK
Melanoma SKMEL
AKI
G361
Bladder cancer DAB-1
T-24
UMUC-2
Cervical cancer HeLa
Epidermoid cancer A431
Breast cancer MCF-7
T-cell lymphoma Jurkat
Promyelocytic leukaemia HL60
Oral squamous cancer HSC-2
Oesophageal cancer TE-8
Pancreatic cancer PCI43c
Total RNA from human cell lines were tested by RT–PCR assay for the expression
of D40 as described in Materials and methods section. D40 expression was observed
in all of the cancer cell lines examined. Representative results on RT–PCR analysis
are shown in Figure 2.
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this gene D40. In the later stage of this study, however, it turned
out that the sequence of D40 is identical with that of the gene
AF15q14 (Hayette et al, 2000), except for the 3' end and several
nucleotides. The nucleotide sequence in D40 cDNA revealed in this
study was deposited in GenBank/EMBL/DDBJ (accession no:
AB022190).
Expression of D40 mRNA is abundant in testis tissue but
not in other normal human tissues
The expression of the D40 gene in various normal human tissues
was examined. Northern hybridisations were performed on
membranes on which multiple human tissue mRNA samples were
blotted as described in the Materials and methods section. The
results revealed that a high level of D40 mRNA expression was
observed in testis tissue and a lower level of expression was
detected in placenta tissue. A major transcript of about 8.5 kilo
base (kb) and a minor one of about 7 kb in size were detected
in the testis tissue. However, D40 expression was not signiﬁcant
in any other normal tissues (Figure 1). With longer exposure of
the Northern blot, slight D40 expression was observed in a few
tissues, far below that in testis tissue (data not shown). These
results indicate that the D40 mRNA is dominantly expressed in
testis tissue.
The D40 gene is expressed in various human cancer cell
lines and primary tumours
We also observed D40 expression in several tumour cell lines as
well as in normal testis tissue. We next examined the mRNA
expression of D40 in various human cancers. When we examined
D40 expression in different human cancer cell lines, we found that
D40 was expressed in the cell lines of four lung cancers, three
melanomas, three bladder cancers, one cervical cancer, one epider-
moid cancer, one breast cancer, one lymphoma, one leukaemia and
tumours derived from the alimentary tract (Table 1). Typical
experimental results are shown in Figure 2.
We then examined D40 expression in human primary tumours.
Total RNAs were prepared from frozen samples of human primary
tumours obtained from surgical operations. Analyses by the RT–
PCR assay on different primary tumours had detected D40 tran-
scripts in signiﬁcant fractions of primary tumour samples, such
as lung cancer, ovary cancer and pancreatic cancer. Typical results
of RT–PCR analyses on the primary tumours are shown in Figure
3. Out of 46 cases of primary lung cancer examined, D40 expres-
sion was observed in 19 cases (more than 40%). Several other
primary cancers also showed D40 expression with comparable or
lower frequencies depending on the types of tumours, such as
ovary cancer, 36%; pancreatic cancer, 27%; and cervical cancer,
38% (Table 2). These results indicate that the D40 gene is
expressed in different human cancers.
Frequent expression of the D40 gene in poorly
differentiated lung tumours and in tumours of smokers
To characterise D40 expression in human primary tumours, lung
cancer was chosen in which to examine the potential correlation
between D40 expression and clinico-pathological characteristics.
The expression of D40 in 46 cases of primary lung cancer was
examined in comparison with several characteristic items and the
examinations were processed with statistical methods. The results
showed that D40 expression has no relation to a patient’s age or
sex, or to a tumour’s histology and pathological stages, such as
tumour size and lymph node metastasis. However, the incidence
of D40 expression was signiﬁcantly higher in poorly differentiated
tumours than well or moderately differentiated ones (P50.04).
Further, signiﬁcantly higher incidence of D40 expression was
observed in primary lung tumours from patients with smoking
habits compared with tumours from non-smokers (P50.02)
(Table 3).
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Figure 1 Northern blot analyses of D40 expression in normal human tissues. Northern hybridisations were performed on membranes on which multiple
human tissue mRNA samples were blotted as described in the Materials and methods section. Expression of D40 mRNA was observed in the testis tissue
sample but not in other normal tissues, except for the placenta sample, which showed trace expression. Arrows indicate the transcripts, 8.5 and 7 kb in
length (upper). The membranes were stripped of D40 probe, then rehybridised with b-actin probe to conﬁrm RNA integrity on the membrane (lower).
D40
b-actin
+     – +     – +     – +     – +     – +     – RT
G361 PC 10 HSC-2 MCF-7 DAB-1 HFL
Figure 2 Expression of the D40 gene in human cancer cell lines analysed
by the RT–PCR assay. To isolate and purify total RNA, about 1610
7 cells
of each human cancer cell line were homogenised in 2 ml of Trizol reagent.
The RT–PCR assay was performed on the puriﬁed RNA as described in
the Materials and methods section. Typical results of RT–PCR analyses
on D40 expressions in cancer cell lines are shown: G361 (melanoma),
PC10 (lung cancer), HSC-2 (oral cancer), MCF-7 (breast cancer), DAB-1
(bladder cancer), HFL (normal ﬁbroblast of lung). RT + or 7 indicates with
or without reverse transcription. The results of b-actin RT–PCR analyses
indicate that the RNA integrity was maintained in all samples.
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In this study, we identiﬁed human gene D40 that is predominantly
expressed in the normal testis tissue, but not in other normal
tissues. A sequence homology search revealed that the D40
sequence is the same as that of the AF15q14 gene (Hayette et al,
2000). This gene is a partner that fuses with MLL, an oncogenic
gene involved in the development of acute leukaemia (Hunger et
al, 1993; Thirman et al, 1994; Hernandez et al, 1995; Dimartino
and Cleary, 1999). In contrast to normal tissues, D40 was expressed
in all human cancer cell lines examined and in several primary
human tumours independently of the types and source of the
tumours. The incidence of D40 expression was signiﬁcantly higher
in tumours derived from smokers as well as in poorly differentiated
tumours.
Most testis-speciﬁc genes are either never or very rarely activated
in tumours (De Smet et al, 1997). However, recent studies, have
disclosed a class of genes that is expressed both in the normal testis
tissue and in cancer. They are referred as cancer/testis (CT) genes
or CT family genes. The expression proﬁle of the D40 gene resem-
bles that of CT genes, suggesting that D40 is also a member of this
family. Some of the CT genes elicit immune response in patients
with malignancies and these are called CT antigens, constituting
several subfamilies of genes, such as MAGE (melanoma antigen)
(Van der Bruggen et al, 1991; Boon et al, 1997; Chen and Old,
1999). They were originally identiﬁed as tumour antigens recog-
nised by cytotoxic T lymphocytes or by antibodies in the sera of
patients with cancer (Sahin et al, 1995; Boon et al, 1997; Chen
and Old, 1999). Further study is needed to determine whether
D40 protein elicits immune responses in patients with cancer.
Very few reports have described the relationship between the CT
gene and clinico-pathological characteristic, The size of a primary
hepatocellular carcinoma is reportedly larger and the serum a-feto-
protein level is reportedly lower in MAGE-positive than in MAGE-
negative patients (Suzuki et al, 1999). To our knowledge, no one
has reported that expression of a CT gene is signiﬁcantly correlated
to the smoking habits of patients, as this study revealed.
We questioned why a gene expressed in the testis in a restricted
manner would be expressed frequently in different human
tumours. A clue might be found in the experimental data from
primary lung cancer indicating that poorly differentiated tumours
and tumours from smokers express D40 at high frequency. Tobac-
co smoke contains a mixture of highly mutagenic chemicals, such
as benzo(a)pyrene and 4-methylnitrosoamine-1-(3-pyridyl)-1-buta-
none. Benzo(a)pyrene induces point mutations such as G to T
transversion (Ruggeri et al, 1993) and forms DNA adducts at the
major mutational hot spots of the p53 gene in lung cancer (Denis-
senko et al, 1996). The mutagen 4-methylnitrosoamine-1-(3-
pyridyl)-1-butanone causes epigenetic alterations of the genome
through the modiﬁcation of DNA methyltransferase activity
(Belinsky et al, 1996). Cellular genes, including D40, which are
barely expressed in normal cells, may be dysregulated so that they
are expressed abnormally when exposed to these chemicals in
tobacco smoke. Compared with well-differentiated lung tumours,
poorly differentiated tumours may be more deviated from the
normal state in gene regulation. The poorly differentiated tumour
cells may arise through the accumulation of dysregulated gene
expressions affected by mutagenic chemicals in tobacco smoke.
In contrast to D40, expression of the actin regulatory protein,
gelsolin, is signiﬁcantly reduced in primary lung tumours of
patients with a smoking habit (Dosaka-Akita et al, 1998). Expres-
sion of the tumour suppressor p16 (INK4a) gene is often
suppressed in tumour cells and p16 promoter is methylated by
smoke (Kim et al, 2001). The components of tobacco smoke might
affect D40 expression by inducing mutations of D40 promoter
DNA or changes of DNA methylation and histone acetylation
status. As methylation of promoter DNA leads to transcriptional
repression of the genes in general, D40 promoter DNA is probably
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Figure 3 Expression of D40 mRNA in primary human cancer assayed by
RT–PCR. Typical experimental results of RT–PCR analyses of D40 ex-
pression in primary cancer. D40 mRNA expression was analysed in total
RNA from primary lung tumours and from normal lung as described in
the Materials and methods. Numbers are individual primary lung tumours
from smokers and non-smokers. RT + or 7 indicates with or without re-
verse transcription. Levels of b-actin in same RNAs were analysed by RT–
PCR to conﬁrm sample integrity.
Table 2 Expression of D40 mRNA in human primary tumours
Tumour type Positive sample/total sample (% positive)
Lung cancer 19/46 (41%)
Ovary cancer 4/11 (36%)
Pancreatic cancer 3/11 (27%)
Cervical cancer 3/8 (38%)
Colon cancer 1/8 (13%)
Glioblastoma 1/5 (20%)
Cholangiocarcinoma 0/7 (0%)
Stomach cancer 0/4 (0%)
Seminoma 0/3 (0%)
Human primary tumours were examined in the expression of D40 by the RT–PCR
assay as described in Materials and methods section. The presence of ampliﬁcation
products in agarose gel is regarded as positive result. Numbers in parenthesis are
the percentages of positive sample.
Table 3 Relationship between D40 expression and clinical and clinico-
pathological characteristics in 46 cases of lung cancers
D40 expression
Characteristics (7) (+) P
Age (mean+s.d.) 63.8+11.5 64.7+12.5 NS
a
Sex
Male 18 15 NS
Female 9 4
Smoking
Non-smoker 10 1 0.02
Smoker 17 18
Histology
b
Squamous 9 4 NS
Adeno 18 10
Large cell 0 3
Small cell 0 2
Differentiation
Well and moderate 19 7 0.04
Poor 8 12
pT classiﬁcation
c
17 2 N S
2–4 20 15
pN classiﬁcation
c
01 2 8 N S
1–3 15 9
aNS, not statistically signiﬁcant.
bSquamous, squamous cell carcinoma; adeno, adeno-
carcinoma; large cell, large cell carcinoma; small cell, small cell carcinoma.
cpT and pN
classiﬁcations are only for squamous cell carcinomas, adenocarcinomas and large cell
carcinomas.
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in D40 promoter may be acetlylated by chemicals in smoke. Tran-
scriptional repressor or activator that binds to the D40 promoter
might be inactivated or activated, respectively, by mutation of their
genes or nucleosome modiﬁcation of their promoters. The molecu-
lar basis of how mutagenic chemicals in tobacco smoke cause both
increases and decreases in gene expression during carcinogenesis
should be revealed by future studies.
As CT antigen could represent the ideal immuno-therapeutic
agent against cancer, extensive studies have identiﬁed dozens of
genes in the CT family. In contrast, very few studies have revealed
their physiological functions or clinico-pathological characteristics
of their expressions. The above information could be quite impor-
tant for characterising the CT genes and when considering the
treatment of cancer patients with immunotherapy. As the carboxy
terminal region of D40/AF15q14 protein contains a nuclear locali-
sation signal, it may be a nuclear protein (Hayette et al, 2000). This
protein may play important roles in gene regulation, such as at the
levels of transcription and mRNA processing. As D40/AF15q14
does not contain other conserved amino acid motifs or domains
with known functions, this protein might have a veiled function
in gene regulation. As individual tumour express different CT anti-
gens, time is required to determine which CT antigen is expressed
in the tumour before the patient is treated with immuno-therapy.
If this could be predicted from the clinico-pathological ﬁndings of
the tumours and determined quickly, treatment would be facili-
tated.
In summary, this study revealed that D40/AF15q14 is a new
gene in cancer/testis family and its expression is signiﬁcantly
related to smoking. This study would contribute to further under-
standings of the mechanism of aberrant CT gene expression in
tumours and to the application of CT genes for immunotherapy
against cancer.
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